The article presents an overview of modern methods of diagnosis, treatment and prevention of acute bronchitis (AB). The prevalence of viral AB is emphasized; it raises questions about advisability of appointing antibacterial agents. The use of antibiotics for viral AB to prevent bacterial complications is also doubtful because effectiveness of this approach has no serious evidence. Influenzal bronchitis requires antiviral therapy using neuraminidase inhibitors. The choice of antitussives based on their mechanism of action and antitussive activity is discussed.

Keywords: antitussives, neuraminidase inhibitors, acute bronchitis, antibiotics